Tor Vergata Atherosclerosis Registry: Identification of biomarkers for cardiovascular events and mortality

Completed

• Conditions: Atherosclerosis and diabetes; Circulatory System

• Registration Number: ISRCTN42405215
• Lead Sponsor: niversity of Rome Tor Vergata Department of Systems Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-10-19
• Last Update Posted: 28 November 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

Patients were diagnosed with established and documented atherosclerotic vascular disease at the atherosclerosis ambulatory clinic that includes cardiology, diabetology and vascular surgery specialists. All the patients have had a major CV event or undergone a vascular procedure for significant vascular stenosis.

Exclusion Criteria

1. Liver disease
2. Renal insufficiency
3. Heart failure
4. Coagulopathy
5. Any other severe systemic disease
6. Positive blood tests for HIV, hepatitis B, or hepatitis C

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Mortality is measured using the phone interview confirmed by hospital records at yearly follow-up<br>2. Cardiovascular mortality is measured using the phone interview confirmed by hospital records at yearly follow-up<br>

Secondary Outcome Measures

Name	Time	Method
on-fatal cardiovascular events (AMI and Stroke) are measured using the phone interview confirmed by hospital records at yearly follow-up.